Earth Science TechETST +6.67%37 Gross Margin % is 66.06% as of Mar. 2026, which is 56% above its 10-year median of 42.34. GuruFocus rates ETST with a GF Score™ of 37/100 and a GF Value™ of $0.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 935 Drug Manufacturers companies, Earth Science Tech ranks better than 83.1% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Earth Science Tech had a gross margin of 66.06% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Earth Science Tech Gross Margin % Related Terms
Earth Science Tech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Earth Science Tech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETST vs SCYX, INIS, TLPH: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Earth Science Tech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earth Science Tech Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Earth Science Tech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Earth Science Tech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Earth Science Tech (ETST) has a Gross Margin % of 66.06% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Earth Science Tech and its competitors. This is 56% above median its historical median of 42.34. According to the industry distribution chart, Earth Science Tech ranks #158 out of 935 companies in the Drug Manufacturers industry, placing it in the top 16.9%.
Is Earth Science Tech's Gross Margin % too high?
Earth Science Tech's current Gross Margin % of 66.06% is 56% above median its 10-year median of 42.34. The Drug Manufacturers industry median Gross Margin % is 48.54. Earth Science Tech's value of 66.06% is 36.1% above this industry median. Based on the distribution chart, Earth Science Tech ranks #158 out of 935 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Earth Science Tech has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Earth Science Tech's Gross Margin % compare to SCYX and INIS?
According to the Drug Manufacturers industry distribution chart, Earth Science Tech ranks #158 out of 935 companies for Gross Margin %. This places Earth Science Tech in the top 17% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Earth Science Tech's value of 66.06% is 36.1% above this benchmark. While the company's 10-year median is 42.34 vs. the industry median of 48.54, Earth Science Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Science Tech's current Gross Margin % of 66.06% is 36.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Earth Science Tech and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Science Tech's current Gross Margin % is 66.06%, which is 56% above median its own 10-year median of 42.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Science Tech stock overvalued right now?
Based on GuruFocus' analysis, Earth Science Tech (ETST) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.16 — trading 30.4% below its estimated fair value. The current Gross Margin % is 66.06%, which is 56% above median its 10-year median of 42.34 and 36.1% above the Drug Manufacturers industry median of 48.54. Earth Science Tech's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Earth Science Tech (ETST), the current Gross Margin % is 66.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Earth Science Tech (ETST) Overvalued in 2026?
Based on GuruFocus' analysis, Earth Science Tech stock appears to be undervalued.
The current stock price of $0.16 is trading 30.4% below its estimated GF Value™ of $0.23.
GuruFocus considers Earth Science Tech to be Possible Value Trap.
Key valuation signals for ETST:
Gross Margin %: 66.06% (56% above median its 10-year median of 42.34)
GF Value™: $0.23 vs. price of $0.16 (30.4% below fair value)
Industry Position: 36.1% above the Drug Manufacturers median (#158 of 935)
No single metric tells the full story. See the ETST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Earth Science Tech Inc is a diversified holding company. The company focuses on the health and wellness sector. The Company's principal operating plan is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment.
37GF Score
Get the complete analysis for ETST
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ETST has been successfully added to your 
